Ginkgo Bioworks Acquires Proof Diagnostics
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Sid Shenai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
BOSTON, Feb. 28, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, announced the acquisition of Proof Diagnostics, an...
COVID-19 drove an investment boom that pushed diagnostics innovation, but newer technologies could be in a precarious position as public funding and test sales slow.
Proof Diagnostics recently submitted a CRISPR-based, point-of-care test for SARS-COV-2 to the US Food and Drug Administration for Emergency Use Authorization.